GENETIC MECHANISMS OF HIGH ALTITUDE DEVELOPMENT PULMONARY ARTERIAL HYPERTENSION
Abstract
генетические механизмы развития высотной легочной артериальной гипертензии
References
1. Weir Е.К, Tucker А , Reeves J Т., et al. The genetic factor influencing pulmonary hypertension in cattle at high altitude. // Cardiovasc Res. 1974.V. 8. P. 745 - 749.
2. Aguirre J.I., Morrell N.W., Long L., et al. Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia // Am. J Physiol. 2000. V. 278. P 981- 987.
3. Lin Z P., Yiao Q.Y., Miao C.Y, et al. Family susceptibility to high altitude heart disease. /High Altitude Disease, W.Y Zhang YB, Liu X L , eds. Qinghai Press, Xining, China; 1984 P 268-287.
4. Wu Т., Wang X., Wei C., et al. Hemoglobin levels in Qinghai—Tibet: different effects of gender for Tibetans vs. Han.// J. Appl Physiol 2005. V. 98(2). P. 5898-6004.
5. Beall C.M. Tibetan and Andean patterns of adaptation to high-altitude hypoxia.// Hum Biol 2000. V .72(l). P 201-228.
6. Moore L.G. Human genetic adaptation to high altitude.//High Alt Med Biol. 2001 V.2. P. 257-279.
7. Su B., Xiao С , Deka R , et al.Y chromosome haplotypes reveal prehistorical migrations to the Himalayas.// Hum Genetics. 2000. V.107(6). P. 582-590.
8. Rupert J.L.,Koehle M.S. Evidence for genetic basis for altitude-related illness.//High Alt med Biol. 2006. V. 7(2). P. 150-67
9. Ge R.-L., and Helun H. Current concept of chronic mountain sickness: pulmonary' hypertension-related high-altitude heart disease. // Wilderness Environ Med. 2001. V. 12. P. 190-194.
10. Garruto R.M., Chin C.T., Weitz C.A., et al. Hematological differences during growth among Tibetans and Han Chinese bom and raised at high altitude in Qinghai, China.// Am J Phys Anthropol. 2003. V. 122. P. 171-183.
11. Gupta М., Rao К., Anand I., et al. Lack of smooth muscle in the small pulmonary arteries of the native Ladakhi. Is the Himalayan highlander adapted9 // Am Rev Respir Dis. 1992.V. 145. P. 1201-1214
12. Sagnella G A , Rotwell M J., Opimpla A К , et al. A population study of ethnic variations in the angiotensin- converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired qlucose metabolism. / / J. Hypertens. 1999. V.17(5). P 657-664.
13. Milledge J.S., and Catley D M . Angiotensin converting enzyme response to hypoxia in man: its role in altitude acclimatization.// Clin Sci. 1984. V.67. P 453—456.
/14. Hotta J., Hanaoka М., Droma Y, et al Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects.// Chest. 2004. V. 126 P 825-830.
15. Charu R , Stobdan Т., Ram R.B., et al. Susceptibility to high altitude pulmonary edema: role of ACE and ET-1 polymorphisms.// Thorax. 2006. V 61(11). P.1011- 1012.
16. Dehnert C , Weymann J., Montgomery H E., et al. No association between highaltitude tolerance and the ACE I/D genepolymorphism.//Med Sci Sports Exerc. 2002.V.34 P 1928-1933.
17. Kumar R , Pasha Q., Khan A.P., et al. Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema.// Aviat Space Environ Med. 2004 V.75. P 981-983.
18. Montgomery H E., Marshall R , Hemingway 11., et al. Human gene for physical performance.//Nature. 1997. V.393. P. 221-222.
19. Aldashev A. A., Sarybaev A. S., Sydykov A S et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz, association with angiotensin-converting enzyme genotype.// Am. J. Respir. Crit. Care Med. 2002.Vol. 166. P.1396-1402.
20. Morrell N.W., Sarybaev A S., Alikhar A., et al. ACE genotype and risk of high altitude pulmonary hypertension in Kyrghy2 highlanders.//Lancet. 1999 V. 353. P. 814
21. Villard E , Tiret L , Visvikis S., et al Identification of new polymorphism of the angiotensin-converting enzyme (ACE) gene and study of their relationship to plasma ACE levels by two-QTL segregation-1 inkage analyses.// Am J Hum Gent. 1996. V.58 P. 1268-1278.
22. Keavney В , McKenzie С , Connell J , et al. Haplotype analyses of the angiotensin I-converting enzyme gene.// Human Molecular Genetics. 1998. V. 7(11). P. 1745-1751.
23. McKenzie C., Abecasis G , Keavney В , et al Trans-ethnic fine mapping of quantitative trait locus for circulating angiotensin I-converting enzyme (ACE).// Human Molecular Genetics 2001. V. 110(10). P. 1077-1084
24. Rabinovitch M, Mullen M, Rosenberg HC, et al. Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat.// Am J Physiol. 1988. V 254(3 Pt 2). H500-8
25. Aldashev, A A., Borbugulov U., Davletov В , et al. Human adrenoceptor system response to the development of high altitude pulmonary arterial hypertension // J. Mol. Cell. Cardiol. 1989. № 21(suppl.l). P 175-179
26. Weitzenblum E, Mammosser M, Ehrhart M. Evolution and prognosis of pulmonary hypertension in chronic obstructive pulmonary disease. / / Herz 1986. V 11. P I47—154
27. Sarton C , Vollenweider L., Loffler B.M, Delabays A., Nicod P., Bartsch P., and Scherrer U. (1999). Exaggerated endothelin release in high-altitude pulmonary edema. Circulation. 99:2665-2668.
28. Kojonazarjv B.K., Isakova J., Imanov В , Sovkhozova N., Sooronbaev Т., Ishizaki Т., Aldashev A.A (2012) Bosentan reduces pulmonary artery pressure in high altitude residents. High altitude Biol.Med (in press).
